If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Similarities Between Pre-Eclampsia and Atherosclerosis: A Protective Effect of Physical Exercise?

$63.10 plus tax (Refund Policy)

Buy Article:

Abstract:

Pre-eclampsia (PE), a characteristic hypertensive disorder of human pregnancy and a leading cause of maternal and fetal mortality and morbidity worldwide, shares some similarities with atherosclerosis, namely the involvement of oxidative stress and of endothelial dysfunction in their pathophysiologies, the presence of similar typical lesions and of common risk factors. Although it is widely accepted that regular physical exercise protects against cardiovascular events, few studies have addressed the impact of physical activity in reducing PE risk. In this paper, similarities between atherosclerosis and PE, involving pathogenic mechanisms, are described. This paper also reviews the studies performed until now that evaluated the impact of regular physical exercise (prenataly or during pregnancy) in reducing risk of PE. The potential mechanisms underlying physical activity as a prophylactic approach of PE, as observed with cardiovascular diseases, are discussed.

Keywords: Pre-eclampsia; cardiovascular disease; physical exercise

Document Type: Research Article

DOI: http://dx.doi.org/10.2174/092986708785747553

Affiliations: Department of Biochemistry, Faculty of Pharmacy, University of Porto, 4099-030 Porto, Portugal.

Publication date: September 1, 2008

More about this publication?
  • Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more